FOLD Shariah Compliance
Screening Methodology: AAOIFI
LOCKED
Amicus Therapeutics Inc. Stock Analysis FOLD
United States Health Care Mid Cap Amicus Therapeutics, Inc. is a biotechnology company, which focuses on discovering, developing, and delivering medicines for people living with metabolic diseases. The company is headquartered in Princeton, New Jersey and currently employs 499 full-time employees. The company went IPO on 2007-05-31. Its two marketed therapies are Galafold, the first oral monotherapy for people living with Fabry disease who have amenable genetic variants, and Pombiliti + Opfolda, a novel treatment designed to improve uptake of active enzyme into key disease relevant tissues for adults living with late-onset Pompe disease. As an orally administered monotherapy, Galafold is designed to bind to and stabilize an endogenous alpha-galactosidase A (alpha-Gal A) enzyme in those patients with genetic variants identified as amenable in a Good Laboratory Practice (GLP) cell-based amenability assay. Pombiliti + Opfolda consists of a uniquely engineered rhGAA enzyme, cipaglucosidase alfa-atga, with an optimized carbohydrate structure to enhance lysosomal uptake, administered in combination with miglustat that functions as an enzyme stabilizer.
Read More FOLD Chart
Amicus Therapeutics Inc vs S&P 500 Comparative Returns
Analysis of FOLD stock performance compared to the broader market (S&P 500) across multiple timeframes.
YTD Performance
- Amicus Therapeu... (FOL...) -35.46%
- S&P 500 -4.27%
Amicus Therapeu... Underperformed S&P 500 by 31.19%
1Y Performance
- Amicus Therapeu... (FOL...) -40.04%
- S&P 500 8.86%
Amicus Therapeu... Underperformed S&P 500 by 48.90%
3Y Performance
- Amicus Therapeu... (FOL...) -2.41%
- S&P 500 37.21%
Amicus Therapeu... Underperformed S&P 500 by 39.62%
5Y Performance
- Amicus Therapeu... (FOL...) -47.9%
- S&P 500 92.3%
Amicus Therapeu... Underperformed S&P 500 by 140.20%
Key Statistics
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$6.09Volume
9.23MP/E Ratio (TTM)
-52 Week Range
Market Cap
2.67BAvg. Volume
4.84MDividend Yield
-Financial Metrics & Statements
- Per Share Data
- Ratios
- Statements
| Currency: USD | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
Revenue per Share (TTM) | 1 | 1.1 | 1.17 | 1.36 | - |
EBIT per Share (TTM) | -0.94 | -0.74 | -0.73 | -0.26 | - |
Earnings per Share (EPS) (TTM) | - | -0.92 | 0 | 0 | - |
EPS Forward | - | -0.92 | -0.82 | -0.51 | - |
Super Investors
Super Investors are top-performing investors known for their exceptional market strategies and long-term success in wealth creation.
Community-Curated Collections ( With FOLD )
View AllCommunity-Curated Collections are thoughtfully selected groups of stocks or assets, curated by investors and experts based on shared themes, values, or investment strategies.
FAQ's
Halal stocks refer to shares of companies that comply with Islamic finance principles, meaning they do not engage in businesses related to alcohol, gambling, pork, or interest-based financial services.
Alternate Halal Stocks
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
